Ella Jones, PhD
|School||UCSF School of Medicine|
|Address||513 Parnassus Ave, Med Sci|
San Francisco CA 94122
|University of San Francisco||BS||Chemistry||1987|
|University of California, Davis||PhD||Chemistry||1991|
|University of Oxford||Post-doctoral training||Chemistry||1993|
|American Chemical Society||1986||Undergraduate Award in Analytical Chemistry|
|American Chemical Society||1987||Student Award|
|University of California, Davis||1987
||1991||Non-resident Tuition Fellowship|
|University of California, Davis||1991||Outstanding Graduate Student Nominee|
|University of Oxford||1991
||1993||Assoicated Member of Balliol College|
|Mallinckrodt Medical, Inc.||1994||2 Outstanding Patent Awards|
|Monsanto Chemical Company||1997
||2001||Chair of the Monsanto Technical Community, Phosphorus Chapter|
|Solutia, Inc.||2001||Chair of the Solution Science and Engineering Network|
|Department of Defense, Breast Cancer||2009||Peer Reviewer|
|National Institute of Health, Challenge grants||2009||Peer Reviewer|
|Department of Defense, Breast Cancer||2010||Peer Reviewer|
| National Institute of Health, NIBIB Training SEP||2010||Peer Reviewer|
| National Institute of Health, NIBIB Quantum Projects||2010||Peer Reviewer|
|World Molecular Imaging Congress Meeting||2013||Section Chair and Moderator|
|World Molecular Imaging Congress Meeting||2013||Poster Award Recipient|
| Department of Defense, Breast Cancer||2014||Peer Reviewer|
|New York State Department of Health||2015||Peer Reviewer|
|Department of Defense, Breast Cancer||2015||Peer Reviewer|
Dr. Ella Jones has over 12 years of research experience in the private sector pioneering the development of targeted molecules for cancer imaging. At UCSF, Dr. Jones integrated cell biology, protein engineering and synthetic chemistry to develop new reporter systems for in vivo imaging of disease biomarkers. She has been funded by NIH/NCI as a PI and has successfully produced various probes for preclinical and clinical use in optical and nuclear imaging. Her major contributions include the development of COX sensitive probe for breast cancer premalignancy and the prostate specific membrane antigen (PSMA) targeting probe for prostate cancer.
More recently, Dr. Jones has taken a new career path focusing on translational breast cancer research. Her current research focuses on the evaluation of normal breast tissues quantified by MR imaging markers as potential independent breast cancer risk factors. Dr. Jones' vast experience in all modalities of imaging spans from the preclinical to the clinical space. In particular, her experience in PET and MR imaging well positions her to expand her research in the emerging field of hybrid PET/MRI for breast cancer characterization.
breast cancer, breast parenchymal enhancement, breast stroma, MRI, PET
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.